ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

16 links0 made here, not in the record31 judgments2 judges (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT03193190A Study of MultipleImmunotherapy-BasedTreatment Combinations inParticipants WithMetastatic PancreaticDuctal Adenocarcinoma(Morpheus-PancreaticHoffmann-La RochePhase 1/Phase 2 · completedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSPancreatic AdenocarcinomaNo longer in the registry's filing›Nov 14 · Rule based · Not readNot readDRUGSAlbumin-Bound PaclitaxelEntry “Nab-Paclitaxel”, read by our n…›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedGemcitabineIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedOxaliplatinIntervention entry›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorLeucovorinIntervention entry›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorFluorouracilIntervention entry›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorAtezolizumabIntervention entry›Nov 3 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · TestedBackground · partnerCobimetinibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPEGPH20Intervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedMotixafortideEntry “BL-8040”, read by our name rule›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedSelicrelumabIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedBevacizumabIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedSimlukafusp alfaEntry “RO6874281”, read by our name r…›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAB928Intervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTiragolumabIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTocilizumabIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Albumin-Bound Paclitaxel

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Nab-Paclitaxel”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 3Albumin-Bound PaclitaxelClaude Opus 5.5TestedCurrent
Nov 3GemcitabineClaude Opus 5.5TestedCurrent
Nov 3OxaliplatinClaude Opus 5.5ComparatorCurrent
Nov 3LeucovorinClaude Opus 5.5ComparatorCurrent
Nov 3FluorouracilClaude Opus 5.5ComparatorCurrent
Nov 3AtezolizumabClaude Opus 5.5Background · partnerCurrent
Nov 3CobimetinibClaude Opus 5.5TestedCurrent
Nov 3PEGPH20Claude Opus 5.5TestedCurrent
Nov 3MotixafortideClaude Opus 5.5TestedCurrent
Nov 3SelicrelumabClaude Opus 5.5TestedCurrent
Nov 3BevacizumabClaude Opus 5.5TestedCurrent
Nov 3Simlukafusp alfaClaude Opus 5.5TestedCurrent
Nov 3AB928Claude Opus 5.5TestedCurrent
Nov 3TiragolumabClaude Opus 5.5TestedCurrent
Nov 3TocilizumabClaude Opus 5.5TestedCurrent
Nov 14Pancreatic AdenocarcinomaRule based · condition-kind ruleNot readCurrent
Nov 18Albumin-Bound PaclitaxelRule based · role ruleTestedAgrees
Nov 18GemcitabineRule based · role ruleTestedAgrees
Nov 18OxaliplatinRule based · role ruleComparatorAgrees
Nov 18LeucovorinRule based · role ruleComparatorAgrees
Nov 18FluorouracilRule based · role ruleComparatorAgrees
Nov 18AtezolizumabRule based · role ruleTestedOverridden
Nov 18CobimetinibRule based · role ruleTestedAgrees
Nov 18PEGPH20Rule based · role ruleTestedAgrees
Nov 18MotixafortideRule based · role ruleTestedAgrees
Nov 18SelicrelumabRule based · role ruleTestedAgrees
Nov 18BevacizumabRule based · role ruleTestedAgrees
Nov 18Simlukafusp alfaRule based · role ruleTestedAgrees
Nov 18AB928Rule based · role ruleTestedAgrees
Nov 18TiragolumabRule based · role ruleTestedAgrees
Nov 18TocilizumabRule based · role ruleTestedAgrees

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.